Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Cohort Study to Evaluate Safety and Efficacy of Pradaxa (Dabigatran Etexilate) in Patients With Moderate Renal Impairment (Creatinine Clearance 30-50 ml/Min) Undergoing Elective Total Hip Replacement Surgery or Total Knee Replacement Surgery

NCT00847301 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00847301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00847301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Cohort Study to Evaluate Safety and Efficacy of Pradaxa (Dabigatran Etexilate) in Patients With Moderate Renal Impairment (Creatinine Clearance 30-50 ml/Min) Undergoing Elective Total Hip Replacement Surgery or Total Knee Replacement Surgery
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
April 30, 2009
Completion date
July 31, 2014
Enrollment
472 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, thromboembolism